Skip to main content

Featured

GTA & Vancouver Home Sales Fell Again in August — What RBC's "Recovery" Call Actually Means for You

  September 6, 2026  •  Canadian Money Brief Fresh numbers out this week from the Toronto Regional Real Estate Board (TRREB) and Greater Vancouver Realtors (GVR) confirm what a lot of GTA and Metro Vancouver households already feel in their bones: the country's two biggest, most expensive housing markets are still shrinking on paper, even as the Bank of Canada holds rates and the trade war eats into everyone's confidence. At the same time, RBC Economics dropped a report calling this a market that's "finally taking steps" toward recovery. Those two things sound contradictory. They're not — but the gap between them is exactly where you need to be paying attention, whether you're a first-time buyer, a seller sitting on a listing, or a landlord watching your renewal math. What It Means for You: Prices are still down year-over-year in both cities, but the underlying supply picture — fewer new listings, tighter inventory — is the thing actually shifting. That...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment